Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$10.05 - $12.02 $483,595 - $578,390
-48,119 Reduced 3.85%
1,202,240 $12.8 Million
Q1 2024

May 14, 2024

SELL
$11.27 - $13.53 $259,198 - $311,176
-22,999 Reduced 1.81%
1,250,359 $14.9 Million
Q4 2023

Feb 13, 2024

BUY
$8.77 - $10.85 $2.51 Million - $3.1 Million
286,049 Added 28.97%
1,273,358 $13.8 Million
Q3 2023

Nov 14, 2023

SELL
$9.59 - $11.35 $3.56 Million - $4.22 Million
-371,552 Reduced 27.34%
987,309 $9.73 Million
Q2 2023

Aug 14, 2023

BUY
$9.02 - $10.29 $1.21 Million - $1.38 Million
134,239 Added 10.96%
1,358,861 $13.6 Million
Q1 2023

May 12, 2023

SELL
$9.2 - $12.26 $3.19 Million - $4.26 Million
-347,081 Reduced 22.08%
1,224,622 $11.8 Million
Q4 2022

Feb 14, 2023

BUY
$8.72 - $11.56 $9.54 Million - $12.7 Million
1,094,413 Added 229.3%
1,571,703 $17.5 Million
Q3 2022

Nov 14, 2022

BUY
$8.48 - $11.13 $366,293 - $480,760
43,195 Added 9.95%
477,290 $4.15 Million
Q2 2022

Aug 12, 2022

SELL
$9.95 - $12.27 $395,492 - $487,707
-39,748 Reduced 8.39%
434,095 $4.35 Million
Q1 2022

May 12, 2022

BUY
$9.81 - $15.4 $1.19 Million - $1.86 Million
121,000 Added 34.29%
473,843 $4.63 Million
Q4 2021

Feb 11, 2022

BUY
$12.09 - $14.68 $176,514 - $214,328
14,600 Added 4.32%
352,843 $4.2 Million
Q3 2021

Nov 15, 2021

SELL
$13.25 - $15.13 $1.71 Million - $1.96 Million
-129,400 Reduced 27.67%
338,243 $3.96 Million
Q2 2021

Aug 13, 2021

SELL
$12.97 - $16.15 $3.74 Million - $4.66 Million
-288,259 Reduced 38.13%
467,643 $5.64 Million
Q1 2021

May 14, 2021

SELL
$13.59 - $18.54 $228,257 - $311,397
-16,796 Reduced 2.17%
755,902 $8.99 Million
Q4 2020

Feb 12, 2021

BUY
$14.3 - $18.74 $11 Million - $14.5 Million
772,698 New
772,698 $11.8 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Apg Asset Management N.V. Portfolio

Follow Apg Asset Management N.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

News

Stay updated on Apg Asset Management N.V. with notifications on news.